title: [Treatment of renal carcinoma].
abstract: The standard therapy for renal carcinoma is radical surgery. When dealing with single, under 4 cm tumors and in the case of renal tumors in single-kidney patients, the choice therapy is nephrectomy or partial nephrectomy. Response rates in metastatic renal carcinoma using the various immune therapy approaches available range from 15 to 35%, responses being short-lasting.
authors.affiliation: Departamento de Urología, Clínica Universitaria de Navarra, Pamplona.
authors.forename: J
authors.initials: J
authors.lastname: Arocena García-Tapia
authors.forename: J
authors.initials: J
authors.lastname: López Ferrandis
authors.forename: D
authors.initials: D
authors.lastname: Sánchez Zalabardo
authors.forename: J M
authors.initials: JM
authors.lastname: Regojo Balboa
authors.forename: J M
authors.initials: JM
authors.lastname: Fernández Montero
authors.forename: D
authors.initials: D
authors.lastname: Rosell Costa
authors.forename: J E
authors.initials: JE
authors.lastname: Robles García
authors.forename: J J
authors.initials: JJ
authors.lastname: Zudaire Bergera
authors.forename: J M
authors.initials: JM
authors.lastname: Berián Polo
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy*